The University of Oklahoma Health Sciences Center and Stephenson Cancer Center are proud to host the 2018 “END2CANCER: Emerging Nanotechnology and Drug Delivery Applications for Cancer” conference from December 5-7, 2018 in Oklahoma City, Oklahoma, USA.
The focus of the two-day conference is to bridge laboratory research conducted in the areas of nanotechnology and drug delivery to clinical application for the detection, diagnosis, imaging, and treatment of cancer. The conference will bring together leaders in the field who will discuss new and emerging concepts and technologies and challenges in clinical advancement.
Topics in modulating the tumor microenvironment and harnessing the immune system for improved drug delivery and therapy will also be covered in planned thematic sessions. Finally, funding opportunities for cancer nanomedicine from the National Cancer Institute/National Institutes of Health will be presented.
The multi-disciplinary conference will bring together physicians, basic scientists, engineers, physicists, chemists, post-doctoral fellows, high-school and college students, patient advocates, business professionals, educators, and technology transfer specialists. Students and fellows will have an opportunity to present their work as a poster presentation and compete for awards.
A special education session titled “Meet The Investigators” is planned for students, fellows, and young investigators to network and exchange ideas and offer collaborative opportunities during the two-day meeting.
The organizing committee would like to invite you to visit the “Sooner” state of Oklahoma and participate in this exciting conference.